派博傳思國際中心

標(biāo)題: Titlebook: Novel Immunotherapeutic Approaches to the Treatment of Cancer; Drug Development and Paul D. Rennert Book 2016 Springer International Publis [打印本頁]

作者: Osteopenia    時(shí)間: 2025-3-21 18:36
書目名稱Novel Immunotherapeutic Approaches to the Treatment of Cancer影響因子(影響力)




書目名稱Novel Immunotherapeutic Approaches to the Treatment of Cancer影響因子(影響力)學(xué)科排名




書目名稱Novel Immunotherapeutic Approaches to the Treatment of Cancer網(wǎng)絡(luò)公開度




書目名稱Novel Immunotherapeutic Approaches to the Treatment of Cancer網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Novel Immunotherapeutic Approaches to the Treatment of Cancer被引頻次




書目名稱Novel Immunotherapeutic Approaches to the Treatment of Cancer被引頻次學(xué)科排名




書目名稱Novel Immunotherapeutic Approaches to the Treatment of Cancer年度引用




書目名稱Novel Immunotherapeutic Approaches to the Treatment of Cancer年度引用學(xué)科排名




書目名稱Novel Immunotherapeutic Approaches to the Treatment of Cancer讀者反饋




書目名稱Novel Immunotherapeutic Approaches to the Treatment of Cancer讀者反饋學(xué)科排名





作者: Pandemic    時(shí)間: 2025-3-21 20:37
Novel Immunomodulatory Pathways in the Immunoglobulin Superfamily,l domains consist of two “sheets” that consist of beta-strands, as illustrated for a generic Ig-domain (Fig. .). Many IgSF proteins consist of single chains that string together one or more Ig-domains, each with its own intrinsic features. IgSF proteins can have from one to many such domains, and th
作者: FICE    時(shí)間: 2025-3-22 02:00

作者: 有惡臭    時(shí)間: 2025-3-22 04:45
NK Cell Responses in Immunotherapy: Novel Targets and Applications,reviously thought (O’Leary et al. (Nat. Immunol. .507–16, 2006); Nabekura and Lanier (J. Exp. Med. .2455–65, 2014), Sun et al. (Eur. J. Immunol. .2059–64., 2009)), perhaps making them even more attractive as tools to optimize the antitumor immune response. Herein, we review some of the basic biology
作者: exorbitant    時(shí)間: 2025-3-22 10:36
Reversing T Cell Dysfunction for Tumor Immunotherapy,ICR “blockade” is the result of interfering with ICR:ligand interactions on exhausted T cells that preferentially express these markers. However, in some cases, ICR antibodies may actually enhance residual T cell function more directly. In addition, it will be important to consider the contribution
作者: DRAFT    時(shí)間: 2025-3-22 14:19
Immunomodulation Within a Single Tumor Site to Induce Systemic Antitumor Immunity: In Situ Vaccinatnse against tumor-associated antigens (TAAs) while avoiding normal host cells. This strategy has proven difficult because TAAs are highly variable in their immunogenicity and undergo immune editing to escape recognition. In addition, they can differ between tumor types and more importantly between i
作者: 邊緣    時(shí)間: 2025-3-22 20:56

作者: Mhc-Molecule    時(shí)間: 2025-3-22 21:21

作者: 重畫只能放棄    時(shí)間: 2025-3-23 01:43
Targeting the Physicochemical, Cellular, and Immunosuppressive Properties of the Tumor Microenvironstitial fluid interstitial fluid pressure (IFP), reduced perfusion, increased hypoxia), enhanced metastasis, tumor cell cloaking from immune cells, and immune system dysregulation. Experimental studies with PEGPH20, an investigational drug candidate currently in clinical development, have demonstrat
作者: 陳舊    時(shí)間: 2025-3-23 07:16
Book 2016ins (ADCC and ADC, respectively). Bi-specific antibodies can engage multiple tumor targets simultaneously, or can redirect lymphocytes to attack tumor cells. The antigen-binding domains within antibodies can be spliced onto cell stimulatory domains and transduced into T cells or NK cells, creating r
作者: Diatribe    時(shí)間: 2025-3-23 10:57
Paul D. Rennertlit them into living small sub-individuals. Neither is it possible to combine one million mice to create a single giant living mouse. In summary, a thermodynamic system should be neither too small nor too large or complex.
作者: acrobat    時(shí)間: 2025-3-23 17:43
simultaneously, or can redirect lymphocytes to attack tumor cells. The antigen-binding domains within antibodies can be spliced onto cell stimulatory domains and transduced into T cells or NK cells, creating r978-3-319-80662-4978-3-319-29827-6
作者: 反復(fù)拉緊    時(shí)間: 2025-3-23 21:59

作者: famine    時(shí)間: 2025-3-23 23:45

作者: bacteria    時(shí)間: 2025-3-24 02:32
Novel Immunotherapeutic Approaches to the Treatment of CancerDrug Development and
作者: prosperity    時(shí)間: 2025-3-24 07:38

作者: 機(jī)制    時(shí)間: 2025-3-24 13:29

作者: Cerumen    時(shí)間: 2025-3-24 18:35

作者: 組裝    時(shí)間: 2025-3-24 20:18
Paul D. RennertChapters not only cover current progress but anticipate the evolution of cancer treatment across diverse Immune Therapeutic approaches.Covers the varied, diverse aspects of the term "immunotherapy".Ad
作者: condone    時(shí)間: 2025-3-25 02:03
http://image.papertrans.cn/n/image/668405.jpg
作者: 結(jié)構(gòu)    時(shí)間: 2025-3-25 03:56

作者: 高貴領(lǐng)導(dǎo)    時(shí)間: 2025-3-25 11:34
Paul D. Rennertgy and chemical composition. A thermodynamic system is a well-defined quantity of matter which is scalable and which can exchange energy with its environment. Examples of thermodynamic systems are 1 kg of ice, 500 g of alcohol, 450 g of red wine or 1 mole of sulfuric acid. . refers to the possibilit
作者: jocular    時(shí)間: 2025-3-25 12:35
Taylor H. Schreiberle A-2. The entropy is normalized in such a way that S = 0 for liquid water at the triple point. The given values of entropy are for saturated water and correspond to the vapor pressures . (10°C) = 0.01228 bar, . (20°C) =0.02339 bar and . (30°C) = 0.04246 bar). If 1 kg of cold water with a temperatu
作者: 音樂學(xué)者    時(shí)間: 2025-3-25 18:42

作者: ensemble    時(shí)間: 2025-3-25 21:04
Novel Immunomodulatory Pathways in the Immunoglobulin Superfamily,The name of the family is based on early studies demonstrating sequence similarity between the antibody (immunoglobulin) variable and constant domains, showing an ancestral link, and the subsequent identification of proteins with similar sequences, suggesting broad diversification and evolution (Wil
作者: exercise    時(shí)間: 2025-3-26 02:49
Parallel Costimulation of Effector and Regulatory T Cells by OX40, GITR, TNFRSF25, CD27, and CD137:ce of appropriate costimulatory molecules. These costimulatory molecules are diverse, and include members of the Immunoglobulin (Ig) and TNF receptor superfamilies. In general, costimulatory molecules are induced by innate immune stimuli and their expression is transient, signaling the presence of a
作者: 暫時(shí)中止    時(shí)間: 2025-3-26 08:13

作者: drusen    時(shí)間: 2025-3-26 12:06
Reversing T Cell Dysfunction for Tumor Immunotherapy,eved in some cases with monoclonal antibodies targeted to immune checkpoint receptors (ICRs) have encouraged the widespread search for other potential molecules that might serve as effective targets for enhancing immune responses to tumors. A major advantage of these approaches is that they do not r
作者: 有雜色    時(shí)間: 2025-3-26 12:56

作者: 袋鼠    時(shí)間: 2025-3-26 19:41
Novel Targets and Their Assessment for Cancer Treatment,cer patients that were refractory to multiple treatment regimens are the new foundation for oncology treatment. As drug discovery in this field accelerates, the field must focus on human-based biology and build out the appropriate set of tools in order to assess new targets and to predict efficacy i
作者: Cosmopolitan    時(shí)間: 2025-3-26 23:27
The New Frontier of Antibody Drug Conjugates: Targets, Biology, Chemistry, Payloads,. Antibody-drug conjugates (ADCs) are one manifestation of that theory and consist of a highly specific tumor-antigen-targeting monoclonal antibody (mAb) that carries a chemically attached toxin for internalization and release within a tumor cell, facilitating its destruction in a precision manner.
作者: 破譯密碼    時(shí)間: 2025-3-27 01:37
Cellular Therapies: Gene Editing and Next-Gen CAR T Cells,get identification and efficient drug screenings. Cancer cell lines or animal models can be created using a series of genome edits or chromosomal rearrangements. The use of engineered nucleases has greatly facilitated gene editing for research and is showing promise for therapy in many fields. Recen
作者: acolyte    時(shí)間: 2025-3-27 06:50

作者: syring    時(shí)間: 2025-3-27 12:06

作者: 孵卵器    時(shí)間: 2025-3-27 17:40
s the varied, diverse aspects of the term "immunotherapy".Ad.Cancer care is undergoing a radical transformation as novel technologies are directed toward new treatments and personalized medicine. The most dramatic advances in the treatment of cancer have come from therapeutics that augment the immun
作者: hemorrhage    時(shí)間: 2025-3-27 21:15
8樓
作者: BULLY    時(shí)間: 2025-3-27 22:25
8樓
作者: 難解    時(shí)間: 2025-3-28 02:06
8樓
作者: 身心疲憊    時(shí)間: 2025-3-28 08:17
9樓
作者: 委托    時(shí)間: 2025-3-28 12:31
9樓
作者: 集合    時(shí)間: 2025-3-28 18:18
9樓
作者: 遺傳學(xué)    時(shí)間: 2025-3-28 20:12
9樓
作者: epidermis    時(shí)間: 2025-3-29 01:50
10樓
作者: 大量    時(shí)間: 2025-3-29 04:07
10樓
作者: scrape    時(shí)間: 2025-3-29 10:10
10樓
作者: ETCH    時(shí)間: 2025-3-29 15:04
10樓




歡迎光臨 派博傳思國際中心 (http://www.pjsxioz.cn/) Powered by Discuz! X3.5
襄汾县| 彭水| 崇左市| 灌阳县| 额济纳旗| 璧山县| 新绛县| 宝山区| 潜山县| 无为县| 山阴县| 东乌珠穆沁旗| 凤台县| 东乌| 中宁县| 台山市| 安多县| 永胜县| 勃利县| 康乐县| 中牟县| 汉川市| 家居| 南宁市| 科尔| 荣成市| 饶河县| 沅江市| 金山区| 黄石市| 淅川县| 萨嘎县| 彩票| 栖霞市| 同江市| 繁峙县| 东明县| 安义县| 琼结县| 固始县| 安吉县|